Vielight-Supported Study Finds Memory and Brain Function Improvements in Mild Cognitive Impairment Pilot Trial
Summary
Vielight announced a peer-reviewed study published in the Journal of Alzheimer's Disease showing that adults with mild cognitive impairment who used its intranasal-transcranial photobiomodulation technology experienced improvements in memory, cognition, and brain connectivity. The randomized pilot trial of 20 adults found those who received treatment improved in memory and overall cognition compared to sham, with measurable changes in biological markers linked to energy metabolism and inflammation.
Why it matters
This study adds to the growing evidence base for non-invasive, light-based approaches to addressing early cognitive decline. As the global population ages and Alzheimer's disease affects over 55 million people worldwide, photobiomodulation represents a potentially scalable, drug-free intervention that could be used at home to slow or prevent progression from mild cognitive impairment to dementia.
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trial